Nicergoline

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C24H26BrN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JCV8365FWN, chemically known as 10-methoxy-1,6-dimethylergoline-8.beta.-methanol 5-bromonicotinate ester but generally known as nicergoline, which bears US NIH Compound Identifier 4475. European Medicines Agency schedules Nicergoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09226MIG. The term NICERGOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules nicergoline in its Anatomical Therapeutic Chemical (ATC) Classification. NICERGOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicergoline under HS 29396900 and SITC 54146. As of Q4 2014, NICERGOLINE remains the US FDA Preferred Term for this commodity. Nicergoline bears US NLM identifiers UMLS ID C0028008 and NCI Concept Code C84006. SMILES: BRC1CC(C(=O)OCC2CC3(OC)C(N(C2)C)CC2C4C3CCCC4N(C2)C)CNC1.